Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)

Annals of Oncology

Volumn 27, Issue 12, 2016, Pages 2294-2299

  Hagelstein, V ^a   Ortland, I ^a   Wilmer, A ^a   Mitchell, S A ^b   Jaehde, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cancer; German; patient reported outcomes; PRO CTCAE; questionnaire; validation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; FEMALE; GERMANY; HUMAN; MALE; MIDDLE AGED; NEOPLASM; OUTCOME ASSESSMENT; PATHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTINEOPLASTIC AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 85039069458     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw422     Document Type: Article

References (21)

1. Basch, E., Bennett, A., Pietanza, M.C., Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events. J Natl Cancer Inst 103 (2011), 1808–1810.
2. Basch, E., Patient-reported outcomes in drug safety evaluation. Ann Oncol 20 (2009), 1905–1906.
3. Trotti, A., Colevas, A.D., Setser, A., Basch, E., Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 25 (2007), 5121–5127.
4. Division of Cancer Control and Population Sciences, National Cancer Institute. Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™). http://healthcaredelivery.cancer.gov/pro-ctcae/ (10 April 2016, date last accessed).
5. Dueck, A.C., Mendoza, T.R., Mitchell, S., et al. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol 1 (2015), 1051–1059.
6. Kirsch, M., Mitchell, S., Dobbels, F., et al. Linguistic and Content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 19 (2015), 66–74.
7. Reeve, B.B., Mitchell, S., Dueck, A.C., et al. Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials. J Natl Cancer Inst, 106, 2014.
8. Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. The European Organisation for Research and Treatment of Cancer QLQ-C30. A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993), 365–376.
9. Stiff, P.J., Erder, H., Bensinger, W.I., et al. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37 (2006), 393–401.
10. Fayers, P.M., Aaronson, N.K., Bjordal, K., et al., on behalf of the European Organisation for Research and Treatment of Cancer Quality of Life Group, The EORTC QLQ-C30 Scoring Manual. 3rd Edition, 2001 (10 April 2016, date last accessed) Brussels http://www.eortc.be/qol.
11. Agresti, A., Categorical Data Analysis. 2nd Edition, 2002, Wiley-Interscience, New York.
12. Bowker, A., A test for symmetry in contingency tables. J Am Stat Assoc 43 (1948), 572–574.
13. Campbell, D.T., Fiske, D.W., Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 56 (1959), 81–105.
14. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57 (1995), 289–300.
15. Landis, J., Richard, K.G.G., The measurement of observer agreement for categorical data. Biometrika 33 (1977), 159–174.
16. DeVellis, R.F., Scale Development. Theory and Applications. 3rd Edition, 2012, Sage Publications, Thousand Oaks.
17. American Educational Research Association (AERA), American Psychological Association (APA), National Council on Measurement in Education (NCME), Standards for Educational and Psychological Testing. 2014, American Educational Research Association, Washington 2014 edition.
18. Basch, E., Reeve, B.B., Mitchell, S.A., et al. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Natl Cancer Inst, 106, 2014.
19. Dong, S.T., Butow, P.N., Costa, D.S., Lovell, M.R., Agar, M., Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manage 48 (2014), 411–450.
20. Coyne, K.S., Tubaro, A., Brubaker, L., Bavendam, T., Development and validation of patient-reported outcomes measures for overactive bladder. A review of concepts. Urology 68:2 Suppl (2006), 9–16.
21. Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V, Krebs in Deutschland 2009/2010. 9th Edition, 2013 Berlin.